We hope you enjoyed the holidays! Check out how some of our team members spent the season. https://t.co/GnBBCqZE2m
We will be presenting the results of the Phase 3 clinical trial of our investigational cell therapy omidubicel next month at the 2021 TCT Meetings, where we will share efficacy and safety results of this study. Read more in our release: https://t.co/IkDrgzdIRj #TCTM21 https://t.co/8uQ9YoZJVe
At Gamida Cell, we’re developing therapies for patients with #bloodcancers, many of whom might need a blood transfusion. We’re driven to Put Patients First and for #NationalBloodDonorMonth want to shine a light on the impact of donors. Learn more: https://t.co/fp9yl3KrmX https://t.co/7Ri78LgD5U
The needs and experiences of patients are at the core of everything we do. Read about one woman’s personal journey through cancer diagnosis and treatment.
We are developing a pipeline of potentially curative cell therapies, with our lead program in late-stage development.
We combine deep scientific experience with a passion for changing the lives of patients.